Search research articles
Contact Us
Filters
Showing results (1-10 of 106) with videos related to
Page
of 11
Sort By:
Immunology Letters
|
October 8, 2009
Fc receptors: role in biology and antibody therapy
Jan G J van de Winkel
Annual Review of Immunology
|
January 14, 2003
IgA Fc receptors
Renato C Monteiro, Jan G J Van De Winkel
Drug Discovery Today
|
June 24, 2003
Renaissance of cancer therapeutic antibodies
Martin J Glennie, Jan G J van de Winkel
Current Opinion in Immunology
|
July 8, 2008
An integrated science-based approach to drug development
Paul Whi Parren, Jan G J van de Winkel
Best Practice & Research. Clinical Haematology
|
June 11, 2011
Molecular engineering to improve antibodies' anti-lymphoma activity
Matthias Peipp, Jan G J van de Winkel, Thomas Valerius
Immunobiology
|
August 22, 2006
Inefficient antigen presentation via the IgA Fc receptor (FcalphaRI) on dendritic cells
Marielle A Otten, Irene Groenveld, Jan G J van de Winkel, et al.
Molecular Immunology
|
November 5, 2003
Differential binding to human FcgammaRIIa and FcgammaRIIb receptors by human IgG wildtype and mutant antibodies
Kathryn L Armour, Jan G J van de Winkel, Lorna M Williamson, et al.
Trends in Immunology
|
September 12, 2003
Antibody-catalyzed water oxidation: state-of-the-art immunity or ancient history?
Paul W H I Parren, Jeanette H W Leusen, Jan G J van de Winkel
Journal of Immunology (Baltimore, Md. : 1950)
|
September 24, 2002
Mac-1 (CD11b/CD18) as accessory molecule for Fc alpha R (CD89) binding of IgA
Annemiek B Van Spriel, Jeanette H W Leusen, Henriëtte Vilé, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 2, 2004
Direct interaction between FcgammaRI (CD64) and periplakin controls receptor endocytosis and ligand binding capacity
Jeffrey M Beekman, Jantine E Bakema, Jan G J van de Winkel, et al.
Page
of 11
Search research articles
Search
Showing results (1-10 of 106) with videos related to
Sort By:
Page
of 11
Immunology Letters
|
October 8, 2009
Fc receptors: role in biology and antibody therapy
Jan G J van de Winkel
Annual Review of Immunology
|
January 14, 2003
IgA Fc receptors
Renato C Monteiro, Jan G J Van De Winkel
Drug Discovery Today
|
June 24, 2003
Renaissance of cancer therapeutic antibodies
Martin J Glennie, Jan G J van de Winkel
Current Opinion in Immunology
|
July 8, 2008
An integrated science-based approach to drug development
Paul Whi Parren, Jan G J van de Winkel
Best Practice & Research. Clinical Haematology
|
June 11, 2011
Molecular engineering to improve antibodies' anti-lymphoma activity
Matthias Peipp, Jan G J van de Winkel, Thomas Valerius
Immunobiology
|
August 22, 2006
Inefficient antigen presentation via the IgA Fc receptor (FcalphaRI) on dendritic cells
Marielle A Otten, Irene Groenveld, Jan G J van de Winkel, et al.
Molecular Immunology
|
November 5, 2003
Differential binding to human FcgammaRIIa and FcgammaRIIb receptors by human IgG wildtype and mutant antibodies
Kathryn L Armour, Jan G J van de Winkel, Lorna M Williamson, et al.
Trends in Immunology
|
September 12, 2003
Antibody-catalyzed water oxidation: state-of-the-art immunity or ancient history?
Paul W H I Parren, Jeanette H W Leusen, Jan G J van de Winkel
Journal of Immunology (Baltimore, Md. : 1950)
|
September 24, 2002
Mac-1 (CD11b/CD18) as accessory molecule for Fc alpha R (CD89) binding of IgA
Annemiek B Van Spriel, Jeanette H W Leusen, Henriëtte Vilé, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 2, 2004
Direct interaction between FcgammaRI (CD64) and periplakin controls receptor endocytosis and ligand binding capacity
Jeffrey M Beekman, Jantine E Bakema, Jan G J van de Winkel, et al.
Page
of 11